Online citations, reference lists, and bibliographies.
← Back to Search

Viral Inhibition Of Inflammation: Cowpox Virus Encodes An Inhibitor Of The Interleukin-1β Converting Enzyme

C. Ray, R. Black, S. Kronheim, T. Greenstreet, D. Pickup
Published 1992 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cowpox virus effectively inhibits inflammatory responses against viral infection in the chick embryo. This study demonstrates that one of the viral genes necessary for this inhibition, the crmA gene (a cytokine response modifier gene), encodes a serpin that is a specific inhibitor of the interleukin-1 beta converting enzyme. This serpin can prevent the proteolytic activation of interleukin-1 beta, thereby suppressing an interleukin-1 beta response to infection. However, the modification of this single cytokine response is not sufficient to inhibit inflammatory responses. This suggests that cowpox virus encodes several cytokine response modifiers that act together to inhibit the release of pro-inflammatory cytokines in response to infection. These viral countermeasures to host defenses against infection may contribute significantly to the pathology associated with poxvirus infections.
This paper references
10.1073/PNAS.86.16.6126
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
O. Elroy-Stein (1989)
10.1073/PNAS.81.21.6817
Spontaneous deletions and duplications of sequences in the genome of cowpox virus.
D. Pickup (1984)
10.1007/978-94-011-3034-9_330
Substrate specificity of the protease that processes human interleukin-1 beta.
P. Sleath (1990)
10.1038/348091A0
New mammalian expression vectors
B. Moss (1990)
10.1016/0014-5793(88)80640-9
Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type‐2 and urokinases
U. Kiso (1988)
10.1126/SCIENCE.1373520
Molecular cloning of the interleukin-1 beta converting enzyme.
D. Cerretti (1992)
The reactive site of human alpha 2-antiplasmin.
B. Shieh (1987)
10.1016/0014-5793(89)81376-6
Activation of interleukin‐ 1β by a co‐induced protease
R. Black (1989)
10.1016/0042-6822(91)90077-O
Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family.
S. Howard (1991)
10.1073/PNAS.83.20.7698
Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.
D. Pickup (1986)
10.1016/0042-6822(89)90128-1
Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus.
G. Palumbo (1989)
10.1172/JCI113152
Interleukin 1 gene expression in adult T cell leukemia.
Y. Wano (1987)
10.1073/PNAS.86.14.5227
Identification of a monocyte specific pre-interleukin 1 beta convertase activity.
M. Kostura (1989)
Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues.
T. P. Chua (1990)
DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Effect of pyrophosphorolysis and metal ions.
S. Tabor (1990)
10.1101/SQB.1987.052.01.060
The serpins: evolution and adaptation in a family of protease inhibitors.
R. Carrell (1987)
Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells.
R. Schindler (1990)
10.1126/SCIENCE.2643161
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.
B. Ensoli (1989)
10.1016/0042-6822(91)90853-4
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence.
C. Upton (1991)
10.1073/PNAS.83.21.8122
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
T. R. Fuerst (1986)
10.1016/0042-6822(90)90294-2
The complete DNA sequence of vaccinia virus.
S. Goebel (1990)
10.1182/BLOOD.V77.8.1627.BLOODJOURNAL7781627
Interleukin-1 and interleukin-1 antagonism.
C. Dinarello (1991)
IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
A. Howard (1991)
10.1073/PNAS.84.13.4572
Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.
B. Mosley (1987)
10.1099/0022-1317-70-9-2333
Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.
G. Smith (1989)
Primary structure of the reactive site of human C1-inhibitor.
G. Salvesen (1985)
10.1073/PNAS.84.14.4767
DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.
S. Tabor (1987)
Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor.
D. Johnson (1978)
10.1021/BI00449A001
Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins.
R. Huber (1989)
10.1126/SCIENCE.2160731
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.
C. Smith (1990)
Purification and characterization of human recombinant precursor interleukin 1 beta.
D. Hazuda (1989)
10.1128/JVI.63.2.600-606.1989
Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily.
G. Kotwal (1989)
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta.
D. Hazuda (1988)
Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin.
M. Morii (1983)
10.1016/0378-1119(88)90005-4
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.
D. Smith (1988)
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.
R. Black (1988)
10.1073/PNAS.88.9.4025
Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo.
S. K. Sambhi (1991)
10.1016/0042-6822(92)90472-2
Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo.
T. Fredrickson (1992)
10.1073/PNAS.85.24.9431
A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.
D. Patel (1988)
10.1021/BI00345A008
Structural evidence for leucine at the reactive site of heparin cofactor II.
M. Griffith (1985)
10.1128/JVI.49.3.857-864.1984
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
M. Mackett (1984)
10.1016/0014-5793(79)80532-3
The thrombin cleavage site in bovine antithrombin
H. Jörnvall (1979)
10.1128/JVI.65.9.5105-5110.1991
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.
L. Flamand (1991)
10.1016/0006-291X(91)90929-2
T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.
C. Smith (1991)
10.1016/0014-5793(86)81113-9
Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencing
P. Andreasen (1986)
10.1099/0022-1317-72-3-511
Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily.
G. Smith (1991)
10.1002/j.1460-2075.1991.tb07831.x
A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
C. J. Mcmahan (1991)



This paper is referenced by
10.1016/0092-8674(95)90541-3
Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
M. Tewari (1995)
10.1101/GAD.10.1.1
Life, death, and the pursuit of apoptosis.
E. White (1996)
10.1016/S0960-9822(02)00541-9
The cell-death machine
A. Chinnaiyan (1996)
10.1016/S0092-8674(00)81266-0
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
M. Muzio (1996)
10.1074/jbc.271.44.27802
A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes*
J. Sun (1996)
10.1002/jcb.10139
Caspase cleavage product lacking amino‐terminus of IκBα sensitizes resistant cells to TNF‐α and TRAIL‐induced apoptosis *
K. Kim (2002)
10.1074/jbc.274.19.13650
Decreased Intracellular Superoxide Levels Activate Sindbis Virus-induced Apoptosis*
K. Lin (1999)
10.1124/pr.112.006171
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
F. Di Virgilio (2013)
10.1091/MBC.10.7.2441
Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22.
C. Brancolini (1999)
10.1146/ANNUREV.IMMUNOL.19.1.423
Interleukin-18 regulates both Th1 and Th2 responses.
K. Nakanishi (2001)
10.1038/sj.cgt.7700549
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
H. Zeh (2002)
10.1016/S0074-7696(02)22015-X
Proteinases and their inhibitors in the immune system.
M. Eijk (2003)
10.1016/J.IMMUNI.2005.08.010
Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators.
J. Park (2005)
10.1006/VIRO.1997.8719
Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells.
M. Diaz-Guerra (1997)
10.1016/S0923-2532(99)80027-1
Implications de l'apoptose en pathologie
A. Biola (1999)
An ongoing pulmonary cowpox virus infection suppresses an immune response to OVA peptide delivered to the lungs
C. Hrusch (2011)
NAIPs: Building an Innate Immune Barrier against Pathogenic Bacteria
Eric M. Kofoed (2012)
10.1007/978-1-4615-5391-5
Chemistry and Biology of Serpins
F. Church (1997)
10.1038/cdd.2017.145
Viewing BCL2 and cell death control from an evolutionary perspective
A. Strasser (2018)
Co-Inhibition von epidermal growth factor receptor (EGFR) und insulin-like growth factor-I receptor (IGF-IR):
Ä. Direktor (2007)
10.1517/14712598.6.8.759
Gene therapy for transplantation with viral vectors – how much of the promise has been realised?
P. Tan (2006)
10.3389/fphys.2014.00352
Reactive oxygen species at the crossroads of inflammasome and inflammation
Anantha Harijith (2014)
10.1038/370270A0
Structure and mechanism of interleukin-lβ converting enzyme
K. Wilson (1994)
10.1016/0014-5793(94)00369-6
Structural aspects of serpin inhibition
A. Schulze (1994)
10.1016/S0960-9822(00)00073-7
Apoptosis: Breaking the ICE
M. D. Jacobson (1994)
10.1016/0092-8674(93)90486-A
Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
M. Miura (1993)
10.1016/S0065-7743(08)60734-4
Chapter 21. Interleukin-1 as a Therapeutic Target
D. Tracey (1994)
10.1002/PRO.5560040102
Interleukin‐1βconverting enzyme: A novel cysteine protease required for IL‐1β production and implicated in programmed cell death
N. Thornberry (1995)
10.1016/j.vetpar.2016.02.003
High-level expression and characterization of two serine protease inhibitors from Trichinella spiralis.
Z. Zhang (2016)
10.1016/j.pharmthera.2011.07.003
Allosteric modulation of caspases.
Hans-Georg Häcker (2011)
10.1016/0014-5793(93)80041-R
Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms
S. Shchelkunov (1993)
Cell death in platelets and megakaryocytes : implications for the maintenance of thrombostasis
M. C. H. Clarke (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar